When will Remifentanil Hydrochloride Injection be back in stock?

The FDA lists an estimated recovery date per manufacturer where known; check the FDA note column below. National FDA records do not reflect your local pharmacy's shelf.

How do I get an alert when Remifentanil Hydrochloride Injection changes?

Sign up for a change-only email alert on this page, or subscribe to the RSS or JSON feed. You are notified only when the FDA record changes.

← all medications

Remifentanil Hydrochloride Injection

Brand names: Remifentanil Hydrochloride, Ultiva

Category: Analgesia/Addiction

Unavailable 3Available 6

FDA status: Current · Last FDA update: Sep 18, 2026 · First posted: Jun 28, 2022 (in shortage 4 years 3 months) · 3 manufacturers, 9 listed presentations

As of Sep 18, 2026, the FDA lists Remifentanil Hydrochloride Injection as currently in shortage. Of 9 manufacturer presentations, 3 Unavailable, 6 Available.

Ask your pharmacist: which of the 3 manufacturers below can they order right now, and whether a different strength or form of Remifentanil Hydrochloride Injection is available. For alternatives, talk to your prescriber — see what to do if your medication is in shortage.

Presentation & package NDC	Manufacturer	Availability	FDA note
Remifentanil Hydrochloride, Injection, 1 mg per vial (NDC 0143-9391-10) NDC 0143-9391-10	Hikma Pharmaceuticals USA, Inc.	Unavailable	Estimated recovery: TBD
Remifentanil Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-724-05) NDC 63323-724-05	Fresenius Kabi USA, LLC	Unavailable	Next release September 2026. Check wholesalers for inventory.
Remifentanil Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-723-03) NDC 63323-723-03	Fresenius Kabi USA, LLC	Available	Check wholesalers for inventory
Remifentanil Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-725-10) NDC 63323-725-10	Fresenius Kabi USA, LLC	Available	Check wholesalers for inventory
Ultiva, Injection, 1 mg/1 mL (NDC 72078-034-01) NDC 72078-034-01	Mylan Institutional, a Viatris Company	Available	-
Ultiva, Injection, 2 mg (NDC 72078-035-02) NDC 72078-035-02	Mylan Institutional, a Viatris Company	Available	-
Remifentanil Hydrochloride, Injection, 2 mg per vial (NDC 0143-9392-10) NDC 0143-9392-10	Hikma Pharmaceuticals USA, Inc.	Unavailable	Estimated recovery: TBD
Ultiva, Injection, 5 mg (NDC 72078-036-05) NDC 72078-036-05	Mylan Institutional, a Viatris Company	Available	-
Remifentanil Hydrochloride, Injection, 5 mg per vial (NDC 0143-9393-10) NDC 0143-9393-10	Hikma Pharmaceuticals USA, Inc.	Available	Additional lots will be available. Product will be made available as it is released.

Related medications in shortage

Other Analgesia/Addiction medications currently on the FDA shortage list — useful context if you and your prescriber are weighing alternatives. Always confirm with your pharmacist.

Change log

No changes recorded yet.
Tracking began Oct 1, 2026. We check the FDA every 6 hours; any real change - a manufacturer moving from Limited to Available, a new recovery date, a new listing - shows up here with its date.

Cite this: “FDA drug-shortage status for Remifentanil Hydrochloride Injection (FDA data as of Sep 18, 2026). Shortage Watch, openFDA.”

Get an email when this record changes

One email, only when the FDA changes something for Remifentanil Hydrochloride Injection. You confirm by clicking a link first (double opt-in). No newsletter, no other mail.

Check your inbox - click the confirmation link to activate alerts for Remifentanil Hydrochloride Injection.

Feeds instead of email: RSS or JSON. Unsubscribe anytime; see Privacy.

Embed a live status badge: /badge/remifentanil-hydrochloride-injection.svg

FDA data last synced Oct 1, 2026 (FDA record dated Sep 30, 2026).